Use of Hsp70 as a regulator of enzymatic activity
AssigneeZevra Denmark A/S
InventorsThomas Kirkegaard Jensen, Marja H. Jaattela
Life of this patent
Estimating the term…
Abstract
The present invention concerns a method for modulating the enzymatic activity of an enzyme, wherein said enzyme interacts with BMP, said method comprising the step of administering or inducing Hsp70, or a functional fragment or variant thereof, in a form suitable for allowing interaction between BMP and Hsp70, or said functional fragment or variant thereof, and thereby modulating the enzymatic activity of an enzyme interacting with BMP.
Claims5
A method for treating Gaucher disease in a human comprising orally administering arimoclomol citrate or arimoclomol maleate, or a pharmaceutically acceptable salt thereof, to a human.
Dependencies are inferred from the claim text.